Why is the market design for innovative pharmaceuticals not well understood?
Healthcare ECONOMIST
SEPTEMBER 16, 2024
A lot of people when they look at pharmaceutical prices think they are ‘too high’ or ‘too low’ But the question is, too high or too low relative to what? What are our goals in pharmaceutical pricing. That is the title of a fantastic editorial from Olivença et al.
Let's personalize your content